Dr. Marcio Debiasi, comments directly from Munich, Germany during the European Oncology Congress - ESMO, on the importance of the CURA project for the development of clinical research in Brazil.
Dr. Gustavo Werutsky, comments directly from Munich, Germany during the European Oncology Congress - ESMO, some examples of clinical research promoted by LACOG.
Today I would like to share with you another practical example showing the importance of carrying out researches, here in Brazil (and in South America?) , at all levels and areas, since the main benefitted is the civil society itself, in other words, each one of us.Dr. Luciano Lauria Dib, a bucomaxillofacial surgeon, faculty member and researcher associated with international universities, in collaboration with Dr. Rodrigo Salazar, a Peruvian researcher, and the University of Illinois, USA, and additional physicians, invented an innovative and much cheaper method to manufacture facial prostheses. This new technique allows them to produce facial prostheses using a regular smartphone, free applications and a common 3-D printer.In addition to saving time and money, such technique enables the restoration of faces and also of the self-esteem among patients who suffered injuries associated with cancer of the mouth, nose, jaw or another area of head or neck.As one can see in previous posts published here on the CURE website, the incidence of cancer of head and neck (many of them associated with the HPV virus) has been increasing in a significant manner. According to statistics published by the Brazilian Ministry of Health, this type of cancer may reach up to 30,000 cases per year (in a near future?) ; as a consequence of such disease, surgical removal of portions of face is required, followed by some type of facial reconstruction. However, many of such patients cannot afford those restorative surgeries.Concerned with such scenario Dr. Dib, in conjunction with a multidisciplinary team — all volunteers, created the Instituto Mais Identidade, a non-for-profit organization, to restore the self-esteem of those patients who had their facial appearance modified. This Institute sponsors the installation of such innovative prostheses in such patients and plans to train additional physicians to use that technique.However, like the CURE Project, the Instituto Mais Identidade still suffers with the lack of resources to disseminate such benefits to thousands of patients.
We need a society more aware of the importance of supporting social responsibility projects and creating a culture of donation, both physical and legal, in order to allow these projects to advance, ranging from the scientific researches to the end product, be it a new medicine, a new treatment or a new technique.By Fernanda Schwyter Coordinator, CURE Project
The CURA Project also took the field on June 15 and called on the main superstars who are active in the attack against cancer. The dinner took place at the house of Dr Fernando Maluf, one of the CURA Ambassadors, was organized by the Director of CURA, Fernanda Schwyter and was attended by several specialists, members of the LACOG - Latin American Cooperative Oncology Group and big names in society, from different sectors, who were honoring this project and contributing to this cause, such as the singer Margarete Menezes, who was the godmother of the first dinner in favor of cancer research.
The ceremony for awarding the certificates of the new CURA Ambassadors took place during the Best Of Asco Congress, on June 15 and 16 in the city of São Paulo. From left to right, Dr. Gustavo Werustky - Director of LACOG; Ambassador Dr. Luis Fernando Correia - doctor and journalist for CBN and Globo News; Ambassador Dr. Jorge Landemann - businessman; Dr. MaX Mano - LACOG Oncologist, Fernanda Schwyter - Director of the CURA Project; Dr. Carlos Barrios - President of LACOG.
Faça como a boutique da designer de moda Adriana Degreas e a clínica do Dr. Jose Couto: mostre para todos seu apoio ao Projeto Cura! Adquira os adesivos do Cura e apoie a luta contra o câncer. Escreva para fernanda.schwyter@lacog.org.br
The Best of ASCO will take place on June 15 and 16 in the city of São Paulo. It is an official ASCO event in partnership with LACOG that aims to present the main studies from the American Congress in Brazil to oncologists who were unable to attend the event. Thus, ASCO provides the complete results and the slides of each study presented and invited professionals (both Brazilian and international) present the results, followed by a discussion of the studies. The Best of ASCO aims to disseminate the latest Oncology research to all Brazilian professionals. In this way, the population benefits indirectly, since more up-to-date and qualified oncologists can provide better treatments and thus improve cancer outcomes in Brazil.
Registrations for professionals in the field are FREE! The schedule can be found at this link.
From June 01 to June 5, 2018, the ASCO - American Society of Clinical Oncology will take place. This annual meeting (ASCO Annual Meeting) is always held in the month of June in Chicago, United States. It is considered the world's largest congress on Clinical Oncology, bringing together more than 30,000 doctors and health professionals from around the world. This event presents the results of the most important cancer studies, many of which have an impact on clinical practice.
Event website: https://am.asco.org/How will LACOG participate in ASCO 2018?Lacog will present 3 abstracts at this important event. Two abstracts refer to the EVITA study — an epidemiological study on cervical cancer in Brazil. This study is in progress (these publications were initial results of the research). This study was developed by LACOG in partnership with EVA (Brazilian Gynecological Tumor Group). The third abstract is a study developed by the GBOT (Brazilian Thoracic Oncology Group) in which LACOG supported the planning, analysis and writing of the results.What type of research was carried out?EVITA is an observational study that collected data from patients treated at their respective institutions. The study continues with the follow-up of patients to assess treatment, quality of life, and survival over time. The GBOT study, on the other hand, collected the results of pathology laboratory tests to assess the prevalence of pd-l1 marker positivity in lung tumors. This study is complete and we will be working on its publication.Were these studies conducted by LACOG member doctors?In the EVITA study, several LACOG researchers were included in their respective hospitals and clinics, comprising all Brazilian regions. All participating doctors are members of LACOG. The supervision, conduct of the study, data analysis and publication were carried out at the LACOG Office in Porto Alegre. The PD-L1 lung cancer study was conducted by a group of investment oncologists from GBOT/LACOG and pathologists from reference laboratories in Brazil. The database and statistical analysis were carried out at the LACOG office, which has personnel specialized in clinical research.What is the importance of these studies?The Cervical Cancer Study (EVITA) is the largest study ever conducted in Brazil on the disease. Its objectives are to characterize the patient population (age, age group, income, personal and family history, treatments performed), evaluate screening through the Pap smear (how many women did it, why didn't) and study the quality of life of these patients before and after treatment, using evaluation criteria from the EORTC (European Organization for Research and Treatment of Cancer). The 3 abstracts are available on the LACOG website, the last 3, dated as 2018. The following link is: http://lacog.org.br/publications
A study presented by the Ministry of Health shows that more than half of the young population in Brazil is infected with HPV.
These are data that attract attention: HPV is a virus that can cause various types of cancer, such as that of the cervix, penis, anus, and more recently it has been associated with throat cancer (tonsils and base of the tongue).
Throat cancer is most often associated with smoking and alcoholism. But that has changed in several countries around the world, with HPV being the main causative factor. In some countries in Europe and the USA, throat cancer caused by HPV is already considered an epidemic by some scholars. In Brazil, data show that most of these tumors are still related to tobacco and alcohol.
But that is changing. We currently have several patients with throat cancer caused by HPV even in Brazil.
What about the vaccine? Help? Will it lower the risk of this cancer?
Yes! The HPV vaccine prevents a person from becoming infected with the cancer-causing HPV viruses. If there's no infection — there's no cancer caused by the virus.
And is it effective at preventing infection?
Yes! At the American Oncology Congress this year, a study was presented that evaluated oral infection with the HPV virus after vaccination of young adults. The vaccine showed an efficacy of 88% {46cf1a6c7461ff493d31bdca70d45967bd1ce7048f85e123712b94daa5b61391} in reducing the rate of oral cavity infection in vaccinated individuals.
Brazil has already incorporated the HPV vaccine into the national vaccination schedule. For girls in 2014 and for boys in 2017. However, the adherence rate to the vaccine is still insufficient.
Each of us has to do our part. The question IS CANCER CURABLE? — it should not be answered by doctors alone.
Each one of us has a responsibility to seek a cure for cancer: whether by taking proper care of the patient, researching, adopting healthy lifestyle habits and, FINALLY, VACCINATING AGAINST HPV.
Text prepared by Dr. Aline Chaves — member of LACOG
On the occasion of World Cancer Day (February 4), EORTC - European Organization for Research and Treatment of Cancer and BIG - Breast International Group, entities that support LACOG - CURA, prepared a press release with the objective of increasing awareness of male breast cancer.
Breast cancer is about 100 times less common in men than in women. Due to the rarity of this disease, it is normally excluded from clinical trials and doctors generally use the treatment applied to women. In new investigations carried out, the scientists demonstrated the feasibility of carrying out a therapeutic clinical trial in a rare patient population, which represents 1 {46cf1a6c7461ff493d31bdca70d45967bd1ce7048f85e123712b94daa5b61391} of all breast cancers. The American Cancer Society estimates that around 2,550 new cases of invasive male breast cancer will be diagnosed in the United States in 2018 and that around 480 men will die from this disease. For more information, click on this link: https://www.cancer.org/conte... /DAM/CRC/PDF/Public/8584.00.pdf
Now, CURA and the ARD Foundation joined forces to raise funds to fight cancer. Look forward to our calendar of events!
Because of World Cancer Day (February 4), the EORTC - European Organization for Research and Treatment of Cancer) and the BIG - Breast International Group, entities that support LACOG - CURA, prepared a press release with the objective of raising awareness about male breast cancer.
Recent findings from international breast cancer research confirm that the disease in men and women is undeniably different and that 1 in 3 men affected by the disease is not treated properly. Breast cancer is about 100 times less common among men than among women. Due to the rarity of the disease, they are generally excluded from clinical trials, and doctors generally use the treatment applied to women. In new research, scientists demonstrated the feasibility of pursuing a therapeutic clinical trial in a rare patient population, which represents 1 {46cf1a6c7461ff493d31bdca70d45967bd1ce7048f85e123712b94daa5b61391} of all breast cancers. American Cancer Society It is estimated that in the USA about 2,550 new cases of invasive male breast cancer will be diagnosed in 2018 and about 480 men will die from the disease. For more information, visit this link: https://www.cancer.org/conte…/dam/CRC/PDF/Public/8584.00.pdf
In these difficult days for the country and for public health, EXCELLENT NEWS: the incorporation, by the SUS, of PERTUZUMAB for the treatment of patients with HER2-positive metastatic breast cancer. This represents More LIVES with more QUALITY!!!
See the ordinance that makes the matter official:
Dr. Aline Chaves, an oncologist at LACOG, from the Head and Neck area. A study presented by the Ministry of Health shows that more than half of the young population in Brazil is infected with HPV. These are data that attract attention: HPV is a virus that can cause various types of cancer such as cervical cancer, penis, anus and more recently it has been associated with throat cancer (tonsils and base of the tongue). Throat cancer is most often associated with smoking and alcoholism. But that has changed in several countries around the world, with HPV being the main causative factor. In some countries in Europe and the USA, throat cancer caused by HPV is already considered an epidemic by some scholars. In Brazil, data show that most of these tumors are still related to tobacco and alcohol. But that is changing. We currently have several patients with throat cancer caused by HPV even in Brazil.What about the vaccine? Help? Will it lower the risk of this cancer?Yes! The HPV vaccine prevents a person from becoming infected with the cancer-causing HPV viruses. If there's no infection — there's no cancer caused by the virus.And is it effective at preventing infection?Yes! At the American Oncology Congress this year, a study was presented that evaluated oral infection with the HPV virus after vaccination of young adults. The vaccine showed an efficacy of 88% {46cf1a6c7461ff493d31bdca70d45967bd1ce7048f85e123712b94daa5b61391} in reducing the rate of oral cavity infection in vaccinated individuals. Brazil has already incorporated the HPV vaccine into the national vaccination schedule. For girls in 2014 and for boys in 2017. However, the rate of adherence to the vaccine is still insufficient. Each one of us has to do our part. The question IS CANCER CURABLE? — it should not be answered by doctors alone.Each one of us has a responsibility to seek a cure for cancer: whether by taking proper care of the patient, researching, adopting healthy lifestyle habits and, FINALLY, VACCINATING AGAINST HPV.
On October 10, Salvador came together to fight breast cancer and help with clinical research.
The Magia Rosa show included a performance by the musician Luiz Caldas, organized by the Distribute Project, under the sponsorship of the AMO Clinic and Imagepat. The initiative brought the Soteropolitan audience to the Castro Alves Theater to dance and all proceeds will go to the Healing Project.
It was a beautiful party, full of energy, friends and engaged people, wanting to know more about how to fight cancer.
Among all the exciting moments, we had the presence of the Junior MMA champion Cigano, who officially received his Cura Ambassador diploma on the TCA stage.
We just have to thank everyone present, the Sharing Project and the sponsors, for their support and for the great encouragement of clinical research through the donation to the Cura Project.
On September 26th and 27/09, the Cura Project participated in another edition of the congress All Together Against Cancer in São Paulo. In addition to the stand, where people could learn more about CURA, on the 27th, the LACOG - Latin American Cooperative Oncology Group reflected on the situation of the cancer epidemic and described the benefits and ways of conducting a clinical study in Brazil. The panel “The Benefits of Research and Scientific Innovation in Oncology for Cancer Patients” brought together great specialists in oncology such as Dr. Carlos Barrios, Dr. Sergio Simon, Dr. Fabio Franke. In addition to them, we had the presence of Bob Chapman, representative of the American Cancer Society, the coordinator of the Cure Project, the psychologist Fernanda Schwyter, and the patient Ana Cristina Angrisano, who gave her testimony about participating in clinical research.
This was another opportunity to discuss and disseminate the importance of encouraging clinical research in Latin America.
The strength of a champion can teach you a lot about the fight against cancer!
Junior Dos Santos Almeida, born in Caçador, in the interior of Santa Catarina, moved to Salvador at the age of 18 to try for a better life. He started fighting at the age of 21, after meeting master Yuri Carlton, who introduced him to Jiu-Jitsu in 2005. In 2008, he joined the UFC and won against big names on his way. In 2011, Cigano won the champion belt against Cain Velasquez. The athlete sees difficult moments as just another obstacle in the struggle that is life! Check out the athlete's message: [embed] https://youtu.be/Wybeu1fZqEU[/embed]
Last July, the BEST OF ASCO Brazil event took place at the Renaissance hotel in São Paulo. The meeting included the most important topics discussed at the annual meeting of the American Society of Clinical Oncology, which took place in Chicago. Organized by the Latin American Cooperative Oncology Group (LACOG), the BEST OF ASCO Brazil included a parallel program for debates on the future of cancer treatment in Brazil and a diploma ceremony for the award of diplomas to the first CURA Ambassadors, who are Dr. Fernando Maluf and Dr. Sérgio Simon. The coordinator of the Cura Project, Fernanda Schwyter, presented the diplomas and commented on the importance of to join forces for integrated awareness-raising and fundraising for the network of supporters of the CURA Project, making the research projects developed by LACOG financially feasible.
The consolidation of research activity is one of the solutions to meet the needs of the population, particularly those that depend on the public health system, reducing discrepancies and facilitating access to the best treatments and contributing to the fight against the disease.About the CuraDR Ambassadors. Sérgio Simon has a doctorate in medicine from FMUSP, specializations in Hematology and Clinical Oncology. In addition, he is a member of ASCO, ESMO, SBOC; CEO and founder of GBECAM and Clinical Oncologist and founding partner of the São Paulo Oncology Center.
Check out an interview with Dr. Sérgio:
[embed] https://youtu.be/4YIV2-29Wkk[/embed]
Dr. Fernando Maluf has a doctorate in Urology from FMUSP and is a Clinical Oncologist. He is a member of the Executive Committee of LACOG - CURA, head of Clinical Oncology at the Antônio Ermírio de Moraes Oncology Center of Benedicência Portuguesa de São Paulo. Check out an interview with Dr. Maluf: [embed] https://youtu.be/r9s-uD2c07M[/embed]
Latin America is about to face a cancer epidemic. It is expected that for every 3 people 2 will be diagnosed with the disease in the coming years and there will be more than 1 million deaths annually, according to data from the World Health Organization (WHO), According to the doctor Carlos Barrios, executive director of the Latin American Cooperative Oncology Group - LACOG, one of the alternatives to face this dramatic increase in the number of cancer cases - which will be the leading cause of death in the coming decades -, is the consolidation of regional centers and groups of clinical research. “In Latin America, only 4 {46cf1a6c7461ff493d31bdca70d45967bd1ce7048f85e123712b94daa5b61391} of the global clinical studies in progress, according to surveys conducted by the National Institute of Health in the United States,” says the specialist. It is through research that knowledge is acquired about how the disease develops. The main barriers to the development of clinical research in Latin America include the lack of structure in national or regional organizations dedicated to cancer research, a limited number of qualified and specialized people (for example, statisticians, study supervisors, and other operational members), lack of public recognition of the importance of clinical research, legal and regulatory obstacles in some countries, and, critically, the lack of funding to support research. To address this problem, the CURA Project was born, a LACOG initiative. The Cura Project develops different actions, through music, art, design, sports and events to raise awareness, educate, and raise funds for scientific research in the fight against cancer. “Our intention is to make the population aware of the benefits of research, demystifying the fantasy that participating in studies is being a guinea pig. We want to show that RESEARCH SAVES LIVES! Research generates knowledge, research is treatment, in short, research is much more than we imagine. We need to mobilize society in relation to the topic and create a culture of financial contribution and engagement in scientific research,” he explains Fernanda Schwyter, coordinator of Cura.Read the full article in the Breast International Group magazine, which had its last edition entirely dedicated to Latin America and where you can learn more about the CURA PROJECT. https://www.slideshare.net/ProjetoCura/big-research-infocus-nmero-6-verso-em-portugus
Thank you very much for the Donation.
For credit card donations, we rely on the ease and security of the PayPal platform, which allows us to receive donations from the main national and international credit card brands. Click the button below and make a one-time or monthly donation. Help us fund research to cure cancer.
We are very grateful for your interest in learning about the Cure Project. If you can contribute with a donation in the future, we will be here waiting for your help:)
Thank you for your collaboration in the fight against cancer. Associação Instituto Proyecto CuraCNPJ: 33.188.607/0001-04Banco Santander (Bank Code: 033) Branch: 0995 Current Account: 13.001.079-8
HPV, a sexually transmitted disease caused by the human papillomavirus, is one of the main triggers of cervical cancer. Recently, however, HPV has also been identified as a cause of throat cancer.
The diagnosis can be made by the clinician or the otorhinolaryngologist, through physical examination and subsequent laryngoscopy. The best form of prevention is the HPV vaccine in addition, of course, to the safe practice of oral sex, taking some fundamental precautions such as the use of condoms, which also prevents the transmission of other diseases, including AIDS.
The main symptoms of throat cancer include:
Doubts? Consult your doctor.
Check out the Cura Project Institute donation page and find out how to help! It's just click here!
Follow CURA on social media
© 2023 Cura Project Institute. All rights reserved.
